Tag: Burkitt Lymphoma

  Mark Robinson visits with a therapy dog at UNC Hospitals. Grammy-nominated musician, record producer, and Chapel Hill native Porter Robinson first met pediatric oncologist Dr. Kate Westmoreland in November 2016, when Porter’s younger brother Mark came into Dr. Westmoreland’s care at UNC Hospitals. Three years later, they have raised...

July 2018- Although highly effective, high-intensity cytotoxic treatments for Burkitt lymphoma are available in resource-rich settings, these therapies are usually not feasible in SSA, and lower-intensity continuous infusion approaches are impractical. We review current treatment approaches in SSA and discuss options for risk stratification and individualize therapy.

March 2017 – Diagnosing pediatric Burkitt Lymphoma in sub-Saharan Africa is difficult, as many tools are currently not available. This study found that measuring Epstein-Barr virus DNA could help with setting the diagnosis, prognosis, and predicting the response.

The center for global health of the National Cancer Institute has awarded funding for the research plan proposed by UNC/LCCC and Baylor College of Medicine.The proposal has three aims, all to promote clinical research on pediatric Burkitt Lymphoma in Malawi

June 2016 – This paper describes a paediatric cohort of patients with Burkitt lymphoma, the most prevalent paediatric cancer in Malawi. Using the more intense CHOP-regimen to treat those patients did not improve the outcome significantly.